BTL Aesthetics Reveals New EMFACE Submentum Technology
BTL Aesthetics has expanded its EMFACE platform with the launch of EMFACE Submentum, a ground-breaking technology designed to target double chins and redefine the jawline. This new application uses a powerful combination of Synchronised Radiofrequency (RF) and HIFES technology to treat both skin and fat in the submental area, providing a non-invasive solution to sagging skin under the chin and jaw.
Synchronised RF works by remodelling collagen and elastin to improve skin texture, while HIFES (High-Intensity Focused Electromagnetic Stimulation) specifically tones and lifts the digastric muscle, which plays a key role in chin laxity. The result is a more contoured jawline, reduced sagging, and firmer skin, all achieved without needles or surgery.
The EMFACE Submentum technology has already made a strong impact in the field of medical aesthetics, offering patients an effective and painless alternative to more invasive treatments for double chins.
Dr. Suha Kersh, an aesthetic practitioner who has been using the technology, emphasised its effectiveness, stating, “The submental area and double chin are a major concern for nearly half the patients that we see, and this new treatment has allowed us to address the area directly. We use this in combination with other BTL technologies such as EXION Face and FRF to achieve a superior lift and tightening of tissues, as well as promoting collagen production and regeneration.”
EMFACE Submentum also integrates seamlessly with other BTL technologies, enhancing the overall effectiveness of facial rejuvenation treatments. By combining multiple technologies, aesthetic practitioners can offer patients more comprehensive results, addressing various concerns related to skin laxity and collagen loss.
As the demand for non-invasive treatments continues to rise, EMFACE Submentum is poised to become a popular choice for individuals seeking a defined jawline and firmer skin without the risks or downtime associated with surgical procedures.